• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Web Alert: Medistem to Host Conference Call Today at 12 Noon ET to Discuss Newly Opened Stem Cell Clinic, Other News

Posted on: Monday, 14 August 2006, 06:00 CDT

Medistem Laboratories, Inc. (OTCBB:MDSM) (FWB:S2U), committed to the ethical development of next-generation medical therapies from non-controversial adult stem cell sources, will host a live conference call, with a simultaneous webcast, today at 12 noon ET to discuss recent achievements and events.

Medistem Chairman and CEO, Neil Riordan, Ph.D., will review such milestones as the opening of the Company's first international affiliate stem cell bank and patient treatment clinic. The stem cell facility is operated by Medistem's Costa Rican-based affiliate, the Institute for Cellular Medicine (ICM).

During the conference call, Mr. Riordan will provide an overview of the Company's mission to develop, deliver and commercialize advanced medical therapies based on non-controversial adult stem cells. He will also address investor questions.

To participate, please register online as explained below. The entire webcast will last approximately 30 minutes.

About Medistem Laboratories, Inc.

Medistem Laboratories is an innovative biotechnology company committed to the creation, licensing and commercialization of advanced medical therapies based on non-controversial adult stem cells. The Company intends to use adult stem cells generated from muscle, bone marrow and fat of adult patients seeking treatment, as well as from full-term, healthy placentas and umbilical cords, which the Company believes to be non-controversial sources of stem cells. The Company's business strategy calls for the establishment of a series of clinics and laboratories around the world to deliver unprecedented, next-generation cell therapies to help millions of patients. For more information on Medistem please visit http://www.trilogy-capital.com/tcp/medistem/. Medistem common stock is traded on the Frankfurt, Germany stock exchange under the symbol S2U.

Cautionary Statement

This document does not constitute an offer to sell or a solicitation of an offer to buy any of our securities. Certain statements in this release may be "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. These forward-looking statements may include projections of matters that affect revenue, the ability to develop or license certain technologies; operating expenses or net earnings; projections of capital expenditures; projections of growth; hiring plans; plans for future operations; financing needs or plans; plans relating to the company's products and services; and assumptions relating to the foregoing.

Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking information.

Some of the important factors that could cause the company's actual results to differ materially from those projected in forward-looking statements made by the company include, but are not limited to, the following: technology development limitations, intense competition, risk of business interruption, management of rapid growth, need for additional financing, regulatory approvals and requirements, dependence on key personnel and research, management and other administrative costs.

These factors are discussed in greater detail in the company's Registration Statement on Form SB-2 and its quarterly and annual periodic reports, all as filed with the Securities and Exchange Commission.

Source: Business Wire

More News in this Category